Cargando…
NAD-dependent isocitrate dehydrogenase as a novel target of tributyltin in human embryonic carcinoma cells
Tributyltin (TBT) is known to cause developmental defects as endocrine disruptive chemicals (EDCs). At nanomoler concentrations, TBT actions were mediated by genomic pathways via PPAR/RXR. However, non-genomic target of TBT has not been elucidated. To investigate non-genomic TBT targets, we performe...
Autores principales: | Yamada, Shigeru, Kotake, Yaichiro, Demizu, Yosuke, Kurihara, Masaaki, Sekino, Yuko, Kanda, Yasunari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121607/ https://www.ncbi.nlm.nih.gov/pubmed/25092173 http://dx.doi.org/10.1038/srep05952 |
Ejemplares similares
-
Tributyltin Inhibits Neural Induction of Human Induced Pluripotent Stem Cells
por: Yamada, Shigeru, et al.
Publicado: (2018) -
Low-Concentration Tributyltin Decreases GluR2 Expression via Nuclear Respiratory Factor-1 Inhibition
por: Ishida, Keishi, et al.
Publicado: (2017) -
Structure and allosteric regulation of human NAD-dependent isocitrate dehydrogenase
por: Sun, Pengkai, et al.
Publicado: (2020) -
Molecular basis for the function of the αβ heterodimer of human NAD-dependent isocitrate dehydrogenase
por: Sun, Pengkai, et al.
Publicado: (2019) -
Molecular mechanism of the allosteric regulation of the αγ heterodimer of human NAD-dependent isocitrate dehydrogenase
por: Ma, Tengfei, et al.
Publicado: (2017)